Generics

is-japan-changing-its-attitude-towards-generic-drugs

Will Japan be able to reduce its generic drug prices?

  • Japan
  • |
  • Analysis

The Japanese pharmaceutical market is the second largest pharma market in the world following on the close heels of the US. Although it records annual sales of approximately $64.5 billion (6.45 trillion Yen), only 6.6 percent of its prescription... Read more

twi-guanfacine-hydrochloride-abbreviated-new-drug-application-anda-gets-fda-approval

TWi Pharma gets FDA nod for ADHD drug


  • Taiwan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Taiwan-based TWi Pharmaceuticals has received tentative approval for its Abbreviated New Drug Application (ANDA)... Read more

impending-free-trade-agreement-between-gcc-and-india-will-further-open-up-the-generics-market

Gulf nations woo Indian generic firms


  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: A new report by investment bank Alpen Capital titled, 'The GCC pharmaceutical Outlook', a number of Gulf Cooperation... Read more

dr

DRL launches Alchemia thrombosis generic in India

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Alchemia's commercialization partner Dr Reddy's Laboratories has launched Alchemia's FDA approved generic anti-coagulant product... Read more

actavis-to-sell-generic-astrazeneca-s-crestor

Actavis to sell generic AstraZeneca's Crestor

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: US-based Actavis reached a settlement agreement with AstraZeneca resolving outstanding patent litigation related to Actavis'... Read more

beximco-pharma-exporter-eu

Beximco Pharma enters EU market

  • Rest of Asia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Beximco Pharmaceuticals, a manufacturer of generic pharmaceutical products and active pharmaceutical ingredients in Bangaldesh,... Read more

good-news-for-cancer-patients-who-suffer-fractures-dr-reddy-s-laboratories-launches-generic-version-of-novartis-zometa-injection

Dr Reddy's launches generic fracture drug

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Hyderabad: Dr Reddy's Laboratories (DRL) launched Zoledronic Acid Injection (4 mg/5 mL), a bioequivalent generic version of Novartis' Zometa... Read more

ranbaxy-drug-us

Ranbaxy to market Desvenlafaxine in the US

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Bangalore: Ranbaxy Pharmaceuticals, a wholly owned subsidiary of Ranbaxy Laboratories, has entered into an in-licensing agreement with... Read more

globaldata-new-zealand-pharmaceutical-management-agency-pharmac-is-emphasising-on-generics

GlobalData: New Zealand focuses on generics

  • New Zealand
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: A new study by GlobalData has revealed that New Zealand's Pharmaceutical Management Agency's (PHARMAC) is emphasising on generics,... Read more

gilead-teva-to-settle-patent-case-of-hiv-drug-viread

Gilead, Teva to settle patent case of HIV drug

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Biopharmaceutical companies Gilead Sciences and Teva Pharmaceuticals have decided to settle the ongoing patent litigation concerning... Read more

mylan-will-develop-and-market-insulin-generics-including-biocon-s-glargine-lispro-and-aspart

Mylan to develop, market Biocon generic insulin

  • India
  • |
  • News
  • |
  • By Narayanan Suresh
  • |
  • 0 Comment

Bangalore: India's No 2 biotech company, Bangalore-based Biocon has announced a strategic partnership with global generics major, Mylan,... Read more

cancer-drug-shortage-fda-list

Sun Pharma cancer drug to address shortage

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: The US Food and Drug Administration has approved the first generic version of the cancer drug Doxil (doxorubicin hydrochloride... Read more

Previous 1 3 4 5 6 7

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X